GeoVax Labs, Inc.
GOVXAnalyst Consensus
Price Target Trend
Rating Trend
Recent Price Targets
| Date | Firm | Analyst | Target | Price Then | Source |
|---|---|---|---|---|---|
| Jul 2, 2024 | H.C. Wainwright | Vernon Bernardino | $8.00(-80%) | $41.00 | StreetInsider |
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| Noble Capital Markets | maintain | Outperform | Sep 15, 2026 |
| D. Boral Capital | maintain | Hold | Apr 16, 2026 |
| D. Boral Capital | downgrade | Buy →Hold | Feb 19, 2026 |
| D. Boral Capital | maintain | Buy | Jan 21, 2026 |
| D. Boral Capital | maintain | Buy | Nov 19, 2025 |
| D. Boral Capital | maintain | Buy | Sep 26, 2025 |
| D. Boral Capital | maintain | Buy | Aug 7, 2025 |
| D. Boral Capital | maintain | Buy | Jul 29, 2025 |
| D. Boral Capital | maintain | Buy | Jul 17, 2025 |
| D. Boral Capital | maintain | Buy | Jun 16, 2025 |
| D. Boral Capital | maintain | Buy | May 2, 2025 |
| HC Wainwright & Co. | maintain | Buy | Apr 16, 2025 |
| D. Boral Capital | maintain | Buy | Apr 15, 2025 |
| D. Boral Capital | maintain | Buy | Apr 10, 2025 |
| D. Boral Capital | maintain | Buy | Mar 28, 2025 |
| D. Boral Capital | maintain | Buy | Feb 27, 2025 |
| D. Boral Capital | maintain | Buy | Jan 31, 2025 |
| D. Boral Capital | maintain | Buy | Jan 16, 2025 |
| D. Boral Capital | maintain | Buy | Dec 18, 2024 |
| HC Wainwright & Co. | maintain | Buy | Nov 20, 2024 |
| D. Boral Capital | maintain | Buy | Nov 19, 2024 |
| HC Wainwright & Co. | maintain | Buy | Nov 15, 2024 |
| Noble Capital Markets | maintain | Outperform | Aug 19, 2024 |
| EF Hutton | maintain | Buy | Aug 19, 2024 |
| HC Wainwright & Co. | maintain | Buy | Aug 12, 2024 |
Earnings History
Next report: Mar 26, 2027 · EPS est. $-1.20| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Jul 27, 2026 | $-0.97 | $-2.16 | — | — |
| May 14, 2026 | $-2.62 | $-1.60 | — | — |
| Apr 2, 2026 | $-2.29 | $-4.71 | — | $1.0M |
| Nov 13, 2025 | $-7.75 | $-5.85 | — | $1.0M |
| Jul 28, 2025 | $-8.75 | $-8.69 | $876.1K | $776.1K |
| May 1, 2025 | $-11.25 | $-14.75 | $1.6M | $1.7M |
| Mar 27, 2025 | $-7.50 | $-19.75 | $882.5K | $3.0M |
| Nov 12, 2024 | $-22.75 | $-1.48 | $2.8M | $1.3M |
News
GeoVax Labs (NASDAQ: GOVX - Get Free Report) and 4D Molecular Therapeutics (NASDAQ: FDMT - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations. Profitability This table compares GeoVax Labs
Lisata Therapeutics (NASDAQ: LSTA - Get Free Report) and GeoVax Labs (NASDAQ: GOVX - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Analyst Ratings This is a summary of